Fresenius Group is a global healthcare company headquartered in Bad Homburg vor der Höhe, Germany, with more than 100 years of operating history. The group generates annual revenue of €21.5 billion and employs around 176,000 people across its operations, serving critically and chronically ill patients worldwide through three main operating companies: Fresenius Kabi, which produces pharmaceuticals and clinical nutrition products; Fresenius Helios, Europe's leading private hospital operator; and the separately managed Fresenius Medical Care, the world's leading provider of dialysis products and services, which alone serves approximately 4.5 million dialysis patients globally.
The group's portfolio spans therapy-focused healthcare, biopharmaceuticals, clinical nutrition, medical technology, and care provision. Its geographic reach extends across Europe, the Americas, and other global markets, positioning it as a significant player in system-critical healthcare services and products for patients with serious medical conditions.
